Keros Therapeutics, Inc. Income Tax Expense
Keros Therapeutics, Inc. (KROS) reported Income Tax Expense of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-03
- Keros Therapeutics, Inc. income tax expense (benefit) for the quarter ending 2026-06-30 was $0.00.
- Keros Therapeutics, Inc. income tax expense (benefit) for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Keros Therapeutics, Inc. income tax expense (benefit) for the quarter ending 2025-12-31 was -$1.51M, a 604.67% decline year-over-year.
- Keros Therapeutics, Inc. income tax expense (benefit) for the quarter ending 2025-09-30 was -$1.42M.
- Keros Therapeutics, Inc. income tax expense (benefit) for fiscal 2025 was $4.88M, a 1527.67% increase from fiscal 2024.
- Keros Therapeutics, Inc. income tax expense (benefit) for fiscal 2024 was $300.00K.
- Keros Therapeutics, Inc. income tax expense (benefit) for fiscal 2023 was $0.00.
- Keros Therapeutics, Inc. income tax expense (benefit) for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-03 | $0.00 10-Q · filed 2026-08-03 | -$1.51M derived: sum of 3 quarters · filed 2026-08-03 | -$2.94M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | -$1.51M derived: sum of 2 quarters · filed 2026-05-14 | -$2.94M derived: sum of 3 quarters · filed 2026-05-14 | -$5.16M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | -$1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$2.94M derived: sum of 2 quarters · filed 2026-03-04 | -$5.16M derived: sum of 3 quarters · filed 2026-08-03 | $4.88M 10-K · filed 2026-03-04 |
| 2025-09-30 | -$1.42M 10-Q · filed 2025-11-05 | -$3.65M derived: sum of 2 quarters · filed 2026-08-03 | $6.40M 10-Q · filed 2025-11-05 | $6.70M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | -$2.22M 10-Q · filed 2026-08-03 | $7.82M 10-Q · filed 2026-08-03 | $8.12M derived: sum of 3 quarters · filed 2026-08-03 | $8.12M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $10.04M 10-Q · filed 2026-05-14 | $10.34M derived: sum of 2 quarters · filed 2026-05-14 | $10.34M derived: sum of 3 quarters · filed 2026-05-14 | $10.34M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $300.00K derived: sum of 2 quarters · filed 2026-03-04 | $300.00K derived: sum of 3 quarters · filed 2026-03-04 | $300.00K 10-K · filed 2026-03-04 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-02-26 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $0.00 derived: sum of 2 quarters · filed 2025-02-26 | $0.00 derived: sum of 3 quarters · filed 2025-02-26 | $0.00 10-K · filed 2025-02-26 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | $2.00M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | $2.00M derived: sum of 3 quarters · filed 2024-02-28 | $1.96M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-05 | $2.00M derived: sum of 2 quarters · filed 2024-02-28 | $1.96M derived: sum of 3 quarters · filed 2024-02-28 | $1.96M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.96M derived: sum of 2 quarters · filed 2024-02-28 | $1.96M derived: sum of 3 quarters · filed 2024-02-28 | $2.01M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$38.00K 10-Q · filed 2022-11-03 | -$38.00K derived: sum of 2 quarters · filed 2022-11-03 | $12.00K 10-Q · filed 2022-11-03 | $12.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-04 | $50.00K 10-Q · filed 2022-08-04 | $50.00K derived: sum of 3 quarters · filed 2022-08-04 | $50.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $50.00K 10-Q · filed 2022-05-05 | $50.00K derived: sum of 2 quarters · filed 2022-05-05 | $50.00K derived: sum of 3 quarters · filed 2022-05-05 | $50.00K derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $0.00 derived: sum of 2 quarters · filed 2022-03-09 | $0.00 derived: sum of 3 quarters · filed 2022-03-09 | -$172.00K 10-K · filed 2022-03-09 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | -$172.00K 10-Q · filed 2021-11-04 | -$172.00K derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-05 | -$172.00K 10-Q · filed 2021-08-05 | -$172.00K derived: sum of 3 quarters · filed 2021-08-05 | -$172.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -$172.00K 10-Q · filed 2021-05-06 | -$172.00K derived: sum of 2 quarters · filed 2021-05-06 | -$172.00K derived: sum of 3 quarters · filed 2021-05-06 | -$172.00K derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $0.00 derived: sum of 3 quarters · filed 2021-03-25 | $0.00 10-K · filed 2021-03-25 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-10 | $0.00 derived: sum of 2 quarters · filed 2020-11-10 | $0.00 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-13 | $0.00 10-Q · filed 2020-08-13 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |